|
End-of-day quote
Dhaka S.E.
2026-11-15
|
5-day change | 1st Jan Change | ||
| 63.00 BDT | -0.63% |
|
+4.30% | +21.39% |
| Market Cap | 7.74B 61.95M 56.14M 51.93M 46.85M 88.29M 5.84B 91.41M 624M 247M 3.12B 232M 228M 9.9B | P/E 2024 |
23.2x | P/E 2025 | 11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 12.17B 97.39M 88.25M 81.63M 73.65M 139M 9.18B 144M 981M 389M 4.91B 365M 358M 15.57B | EV / Sales 2024 |
2.09x | EV / Sales 2025 | 1.11x |
| Free-Float |
68.17% | Yield 2024 |
1.6% | Yield 2025 | 2.78% |
| 1 day | -0.63% | ||
| 1 week | +4.30% | ||
| Current month | +6.24% | ||
| 1 month | +1.94% | ||
| 3 months | -9.22% | ||
| 6 months | +1.94% | ||
| Current year | +21.39% |
| 1 week | 62.7 | 65.5 | |
| 1 month | 57.9 | 65.5 | |
| Current year | 50.7 | 78 | |
| 1 year | 48 | 78 | |
| 3 years | 36.2 | 118.9 | |
| 5 years | 26.4 | 132 | |
| 10 years | 26.4 | 132 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mohammad Shafiq
CEO | Chief Executive Officer | 65 | 2020-11-24 |
Hassan Sarwar
DFI | Director of Finance/CFO | - | 2024-06-30 |
Malay Kumar Dey
CTO | Chief Tech/Sci/R&D Officer | 41 | 2020-11-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Saiqa Mazed
CHM | Chairman | - | 2025-04-14 |
Mohammad Shafiq
BRD | Director/Board Member | 65 | 2020-11-24 |
Javed Ally
BRD | Director/Board Member | 56 | 2020-11-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.63% | +4.30% | +34.04% | -24.46% | 54.13M | ||
| +1.14% | +6.61% | +40.79% | +145.27% | 1,286B | ||
| +0.79% | +3.45% | +45.84% | +92.04% | 688B | ||
| +0.20% | +1.28% | +26.97% | +114.41% | 521B | ||
| +0.80% | +1.70% | +42.03% | +72.22% | 386B | ||
| +0.55% | +0.70% | +59.02% | +45.79% | 364B | ||
| +1.06% | +1.45% | +28.00% | +62.68% | 302B | ||
| +0.28% | -0.33% | +3.15% | +37.91% | 287B | ||
| -0.30% | +1.14% | +38.29% | +70.56% | 252B | ||
| +0.08% | +0.71% | +34.44% | +123.99% | 208B | ||
| Average | +0.45% | +1.81% | +35.26% | +74.04% | 429B | |
| Weighted average by Cap. | +0.64% | +3.26% | +37.71% | +99.60% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 6.9B 55.18M 50.01M 46.25M 41.73M 78.64M 5.2B 81.41M 556M 220M 2.78B 207M 203M 8.82B | 8.84B 70.74M 64.1M 59.29M 53.5M 101M 6.67B 104M 712M 282M 3.56B 265M 260M 11.31B |
| Net income | 405M 3.24M 2.93M 2.71M 2.45M 4.61M 305M 4.78M 32.59M 12.92M 163M 12.15M 11.89M 517M | 488M 3.9M 3.54M 3.27M 2.95M 5.56M 368M 5.76M 39.29M 15.58M 197M 14.64M 14.33M 624M |
| Net Debt | 5.03B 40.25M 36.48M 33.74M 30.44M 57.37M 3.8B 59.39M 405M 161M 2.03B 151M 148M 6.44B | 4.43B 35.44M 32.11M 29.7M 26.8M 50.5M 3.34B 52.28M 357M 141M 1.78B 133M 130M 5.67B |
Employees
4,798
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-15 | BDT 63.00 | -0.63% | 398,648 |
| 26-11-12 | BDT 63.40 | -0.78% | 213,516 |
| 26-11-11 | BDT 63.90 | -1.54% | 424,632 |
| 26-11-10 | BDT 64.90 | +2.37% | 520,085 |
| 26-11-09 | BDT 63.40 | +4.97% | 597,936 |
- Stock Market
- Stocks
- NAVANAPHAR Stock
Select your edition
All financial news and data tailored to specific country editions
















